NCT04472208View on ClinicalTrials.gov

AMS Evaluation Study

NACompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

February 26, 2021

Primary Completion Date

October 14, 2021

Study Completion Date

October 14, 2021

Conditions
Patient Monitoring
Interventions
DEVICE

Ambulatory monitoring solution

Subjects participating in this study will be monitored with the site's standard of care primary monitor and the evaluable device as the secondary monitor.

Trial Locations (1)

SW10 9NH

Chelsea and Westminster Hospital, London

Sponsors

Lead Sponsor

GE Healthcare
All Listed Sponsors
lead

GE Healthcare

INDUSTRY